Profits Unlimited

In tech news last week, Forbes reported ChatGPT would be launching an iOS app for mobile users on the go.

This would mark the first ever AI app for iPhones.

The Forbes announcement was accompanied by a flood of headlines from the likes of The Wall Street Journal, FOX, Reuters, CNBC and Business Insider.

Many of which reported on the restriction Apple is putting on its employee usage of the new app.

Since launching in November last year, ChatGPT has dominated the AI conversation in the public square.

But it is far from being the only newsworthy AI development to hit newsstands recently.

For instance, NBC just reported how AI can now detect early signs of lung cancer that doctors can’t see.

Similar stories have been published in the last two months by sources like The New York Times, CNN, Wired, The Guardian and New York Post.

Even the Massachusetts Institute of Technology published a new study. And Bloomberg called an AI drug discovery a $50 billion opportunity for Big Pharma.

All of these outlets have reported on the same remarkable abilities for AI’s early detection of different types of cancers. Including lung, breast and pancreatic cancers that affect millions of Americans each year.

That’s why even the president said new therapies — many of which are only possible because of AI — can “End cancer as we know it.”

It really is a marvel what AI can do now. And it’s unimaginable how much further the technology will go.

That’s why AI has been called the biggest new industry of the 21st century. Experts are projecting it will be worth a staggering $80 trillion over the next 10 years.

That’s ONE THOUSAND times larger than the Bloomberg article reported on AI’s impact on healthcare alone.

And for a limited time, I’m revealing my favorite AI stock right now.

Click here to see the full story.

Legal Notice: This work is based on what we've learned as financial journalists. It may contain errors and you should not base investment decisions solely on what you read here. It's your money and your responsibility. Nothing herein should be considered personalized investment advice. Although our employees may answer general customer service questions, they are not licensed to address your particular investment situation. Our track record is based on hypothetical results and may not reflect the same results as actual trades. Likewise, past performance is no guarantee of future returns. Certain investments carry large potential rewards but also large potential risk. Don't trade in these markets with money you can't afford to lose. Money & Markets permits editors of a publication to recommend a security to subscribers that they own themselves. However, in no circumstance may an editor sell a security before our subscribers have a fair opportunity to exit. Any exit after a buy recommendation is made and prior to issuing a sell notification is forbidden. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication.

(c) 2023 Money & Markets, LLC. All Rights Reserved. Protected by copyright laws of the United States and treaties. This Newsletter may only be used pursuant to the subscription agreement. Any reproduction, copying, or redistribution, (electronic or otherwise) in whole or in part, is strictly prohibited without the express written permission of Money & Markets. P.O. Box 8378, Delray Beach, FL 33482. (TEL: 800-684-8471)

Remove your email from this list: Click here to Unsubscribe.